Literature DB >> 26141175

Subjective and Objective Risks of Carrying a BRCA1/2 Mutation in Individuals of Ashkenazi Jewish Descent.

Kimberly Kelly1, Howard Leventhal, Deborah Toppmeyer, Judy Much, James Dermody, Monica Marvin, Jill Baran, Marvin Schwalb.   

Abstract

This repeated measures study examines (1) the change in subjective risk of mutations pre- to postcounseling, (2) the accuracy of BRCAPRO estimates of mutations, and (3) the discrepancy between subjective risk and BRCAPRO estimates of mutations before and after genetic counseling. Ninety-nine Ashkenazi Jewish individuals pursued testing for BRCA1/2 mutations. Most had a personal cancer history (N = 51; family only: N = 48); and received uninformative negative results (N = 66; positives: N = 23; informative negative: N = 10). The coping strategy of defensive pessimism predicts that individuals will believe the worst case scenario to better cope with a potential negative outcome. Consistent with this, most felt they would have a mutation, if not mutations in both genes. The BRCAPRO model appeared to overestimate risk of having a mutation in this sample (p < .001). BRCAPRO overestimates notwithstanding, genetic counseling increased accuracy of subjective risk (p < .01). Individuals with a family-only cancer history had the least accurate estimates of risk (p < .05) and may need further intervention to either manage anxiety or improve knowledge.

Entities:  

Year:  2003        PMID: 26141175     DOI: 10.1023/A:1023905106360

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

1.  The motivational and emotional consequences of considering positive or negative possibilities for an upcoming event.

Authors:  C Showers
Journal:  J Pers Soc Psychol       Date:  1992-09

2.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Authors:  D A Berry; G Parmigiani; J Sanchez; J Schildkraut; E Winer
Journal:  J Natl Cancer Inst       Date:  1997-02-05       Impact factor: 13.506

3.  BRCA1 Testing: Genetic Counseling Protocol Development and Counseling Issues.

Authors:  B J Baty; V L Venne; J McDonald; R T Croyle; C Halls; J E Nash; J R Botkin
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

Review 4.  Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.

Authors:  G Geller; J R Botkin; M J Green; N Press; B B Biesecker; B Wilfond; G Grana; M B Daly; K Schneider; M J Kahn
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

5.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Authors:  C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed
Journal:  J Natl Cancer Inst       Date:  1997-01-15       Impact factor: 13.506

6.  BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

Authors:  D Shattuck-Eidens; A Oliphant; M McClure; C McBride; J Gupte; T Rubano; D Pruss; S V Tavtigian; D H Teng; N Adey; M Staebell; K Gumpper; R Lundstrom; M Hulick; M Kelly; J Holmen; B Lingenfelter; S Manley; F Fujimura; M Luce; B Ward; L Cannon-Albright; L Steele; K Offit; A Thomas
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

7.  A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.

Authors:  C Lerman; M D Schwartz; S M Miller; M Daly; C Sands; B K Rimer
Journal:  Health Psychol       Date:  1996-03       Impact factor: 4.267

8.  Women's receptivity to testing for a genetic susceptibility to breast cancer.

Authors:  H Chaliki; S Loader; J C Levenkron; W Logan-Young; W J Hall; P T Rowley
Journal:  Am J Public Health       Date:  1995-08       Impact factor: 9.308

9.  Perception of risk in women with a family history of breast cancer.

Authors:  D G Evans; L D Burnell; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  The impact of genetic counselling on risk perception in women with a family history of breast cancer.

Authors:  D G Evans; V Blair; R Greenhalgh; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  6 in total

1.  Perceived risk of cervical cancer in Appalachian women.

Authors:  Kimberly M Kelly; Amy K Ferketich; Mack T Ruffin Iv; Cathy Tatum; Electra D Paskett
Journal:  Am J Health Behav       Date:  2012-11

2.  What does risk of future cancer mean to breast cancer patients?

Authors:  Karen Kaiser; Kenzie A Cameron; Jennifer Beaumont; Sofia F Garcia; Leilani Lacson; Margaret Moran; Lindsey Karavites; Chiara Rodgers; Swati Kulkarni; Nora M Hansen; Seema A Khan
Journal:  Breast Cancer Res Treat       Date:  2019-03-06       Impact factor: 4.872

3.  Linking genetic counseling content to short-term outcomes in individuals at elevated breast cancer risk.

Authors:  Kimberly M Kelly; Lee Ellington; Nancy Schoenberg; Parul Agarwal; Thomas Jackson; Stephanie Dickinson; Jame Abraham; Electra D Paskett; Howard Leventhal; Michael Andrykowski
Journal:  J Genet Couns       Date:  2014-03-28       Impact factor: 2.537

4.  The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.

Authors:  Kimberly Kelly; Howard Leventhal; Michael Andrykowski; Deborah Toppmeyer; Judie Much; James Dermody; Monica Marvin; Jill Baran; Marvin Schwalb
Journal:  J Genet Couns       Date:  2004-06       Impact factor: 2.537

5.  The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.

Authors:  Anita Caruso; Cristina Vigna; Gabriella Maggi; Fabio Massimo Sega; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2008-11-24

Review 6.  A systematic review of the impact of genetic counseling on risk perception accuracy.

Authors:  Chris M R Smerecnik; Ilse Mesters; Eline Verweij; Nanne K de Vries; Hein de Vries
Journal:  J Genet Couns       Date:  2009-03-17       Impact factor: 2.537

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.